a company at the crossroads
of Biotechnology and Molecular
Save millions of lives
by delivering diagnostic
results in 3 hours
Detect and identify 99%
of sepsis pathogens at species level
with revolutionary sensitivity
Sepsis in numbers
people affected annually1
Targeted specific microbial therapy shall be engaged within first hours, whereas blood cultures deliver results in 1-10 days6
in the US2
annually affected people1
Targeted specific microbial therapy shall be engaged within first hours, whereas blood culture deliver results in 1-10 days6
1. World Health Organization https://www.who.int/sepsis/en/
2. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013 (MAY 2016) HCUP Statistical Brief #204
OCEAN offers a patented multiplexing molecular diagnostics kit.
99% sepsis pathogen identification (all Gram positive and Gram negative bacteria)
Results in less than 3 hours
Revolutionary limit of detection of 0.3 cell/ml of blood
Drop mortality from 35% to 5 %, saving millions of lives worldwide
Healthcare cost reduction
Better antimicrobial management, avoiding drug resistance
OCEAN Dx, specialized in in vitro diagnostics for infectious diseases, has announced closure of its initial round of fundraising from Bpifrance and the AJYL business angels (also the leading investors in startups Treefrog Therapeutics and Toopi Organics). The money...
The Start-up OCEAN Dx, specialised in the in vitro diagnostic of infectious diseases (Bordeaux, France), won the i-Nov 2020 contest organized by the French General Secretary for Investment. The 400 000 € prize will help OCEAN Dx to automate its ultra-fast diagnostic...
The Start-up OCEAN Dx, specialised in infectious diseases in vitro diagnostic (Bordeaux, France), won the i-Lab 2020 contest organized by the French Ministry of Higher Education, Research, and Innovation. The 250 000 € prize will enable OCEAN Dx to complete its...